Clinical modifiers of the association between type 1 diabetes and dementia incidence
Pederson, A. M.; Buto, P.; Zimmerman, S. C.; Sims, K.; Murchland, A. R.; Wang, J.; Glymour, M. M.; Weuve, J.; Gilsanz, P.; Chi, F.; Whitmer, R. A.; Brennan, A. T.
Show abstract
BackgroundType 1 diabetes mellitus (T1DM) is associated with elevated dementia risk, but the mechanisms are not well understood. Prior studies suggest that co-occurring diabetes-related complications and other comorbidities may further increase dementia risk, but these studies are few and typically have small samples. Whether diabetes-related complications and other comorbidities modify the effect of T1DM on dementia risk remains unclear. MethodsData are from participants of the All of Us (AoU) cohort ages [≥] 50 years, with complete baseline surveys, linked electronic health records (EHRs), and either T1DM or no DM. Enrollment began in 2017, with data available through October 2023, including information prior to enrollment in AoU. Incident dementia was identified based on ICD-9, ICD-10, and SNOMED codes in participants EHRs. Baseline clinical comorbidities (diabetes complications and eye diseases, other vascular and metabolic comorbidities, and mental health conditions) were also identified using participants EHRs, classifying each as present if at least one diagnostic code occurred on or before the baseline survey. ResultsAmong 232,429 participants (mean [SD] age 64.5 [9.0] years; 57.3% women), 2.3% had a T1DM diagnosis. Participants averaged 1.67 total comorbidities (SD = 2.08). T1DM and each comorbidity was associated with higher dementia incidence. T1DM was associated with higher dementia incidence among individuals with no comorbidities (HR = 1.77; 95% CI: 0.95-3.30), though the CI included 1. Each additional comorbidity increased risk (HR = 1.22; 95% CI: 1.19-1.26), with some evidence that the effect of T1DM differed by the number of comorbidities (HR = 0.94; 95% CI:0.86-1.01). The combined estimated effect of T1DM and most comorbidities was less than multiplicative. Depression was an exception; the dementia HR for individuals with both T1DM and depression (HR = 5.47; 95% CI: 4.23, 7.08) roughly reflected what would have been expected based on the HR for T1DM (HR = 2.01; 95% CI: 1.38, 2.92) times the HR for depression among those without T1DM (HR = 2.55; 95% CI: 2.22, 2.95). ConclusionOur findings suggest that T1DM and common comorbidities independently increase dementia risk, though their combined effects are generally less than multiplicative. However, depression in the context of T1DM is associated with major elevations in dementia risk.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effects of Dipeptidyl Peptidase-4 Inhibitors and Sulfonylureas on Cognitive and Physical Function in Nursing Home Residents 93%
- Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission 91%
- Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study 91%
Similar papers in this journal
- Data-driven subtypes of type 2 diabetes mellitus and risk of dementia, stroke, and brain structural changes in the UK Biobank 93%
- Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin 92%
- Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of diabetic patients based on their cognitive status 90%
Similar papers in this journal
- Sociodemographic Characteristics and Longitudinal Progression of Multimorbidity: A Multistate Modelling Analysis of a Large Primary Care Records Dataset in England 91%
- Differential impact of Covid-19 on incidence of diabetes mellitus and cardiovascular diseases in acute, post-acute and long Covid-19: population-based cohort study in the United Kingdom 90%
- Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting 90%
Similar papers in this journal
- Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017-2019 and 2020 91%
- Metabolome-defined obesity and the risk of future diabetes and mortality 90%
- Early metabolic features of genetic liability to type 2 diabetes: cohort study with repeated metabolomics across early life 89%
Similar papers in this journal
- Multimorbidity and risk of incident dementia: role of disease clusters and genetic risk for dementia in a cohort of 206,960 participants 94%
- The influence of genetic predisposition and physical activity on risk of Gestational Diabetes Mellitus in the nuMoM2b cohort 90%
- Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study 86%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.